Literature DB >> 22082084

Executive functions, categorization of probabilities, and learning from feedback: what does really matter for decision making under explicit risk conditions?

Johannes Schiebener1, Laura Zamarian, Margarete Delazer, Matthias Brand.   

Abstract

In two experiments with healthy subjects, we used the Game of Dice Task (GDT), the Probability-Associated Gambling (PAG) task, the Iowa Gambling Task (IGT), and executive-function and logical thinking tasks to shed light on the underlying processes of decision making under risk. Results indicate that handling probabilities, as in the PAG task, is an important ingredient of GDT performance. Executive functions and logical thinking also play major roles in deciding in the GDT. Implicit feedback learning, as measured by the IGT, has little impact. Results suggest that good probability handling may compensate for the effects of weak executive functions in decisions under risk.

Entities:  

Mesh:

Year:  2011        PMID: 22082084     DOI: 10.1080/13803395.2011.595702

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  20 in total

1.  Self-reported strategies in decisions under risk: role of feedback, reasoning abilities, executive functions, short-term-memory, and working memory.

Authors:  Johannes Schiebener; Matthias Brand
Journal:  Cogn Process       Date:  2015-08-20

2.  Performing a secondary executive task with affective stimuli interferes with decision making under risk conditions.

Authors:  Bettina Gathmann; Mirko Pawlikowski; Tobias Schöler; Matthias Brand
Journal:  Cogn Process       Date:  2013-10-24

Review 3.  Decision Making Under Objective Risk Conditions-a Review of Cognitive and Emotional Correlates, Strategies, Feedback Processing, and External Influences.

Authors:  Johannes Schiebener; Matthias Brand
Journal:  Neuropsychol Rev       Date:  2015-04-18       Impact factor: 7.444

4.  Anchor effects in decision making can be reduced by the interaction between goal monitoring and the level of the decision maker's executive functions.

Authors:  Johannes Schiebener; Elisa Wegmann; Mirko Pawlikowski; Matthias Brand
Journal:  Cogn Process       Date:  2012-08-23

5.  Stress and decision making: neural correlates of the interaction between stress, executive functions, and decision making under risk.

Authors:  Bettina Gathmann; Frank P Schulte; Stefan Maderwald; Mirko Pawlikowski; Katrin Starcke; Lena C Schäfer; Tobias Schöler; Oliver T Wolf; Matthias Brand
Journal:  Exp Brain Res       Date:  2014-01-10       Impact factor: 1.972

6.  Risk approximation in decision making: approximative numeric abilities predict advantageous decisions under objective risk.

Authors:  Silke M Mueller; Johannes Schiebener; Margarete Delazer; Matthias Brand
Journal:  Cogn Process       Date:  2018-01-22

7.  A further evaluation of decision-making under risk and under ambiguity in schizophrenia.

Authors:  Guillaume Fond; Sophie Bayard; Delphine Capdevielle; Jonathan Del-Monte; Nawale Mimoun; Alexandra Macgregor; Jean-Philippe Boulenger; Marie-Christine Gely-Nargeot; Stéphane Raffard
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-05-26       Impact factor: 5.270

8.  The Allure of High-Risk Rewards in Huntington's disease.

Authors:  Nelleke C van Wouwe; Kristen E Kanoff; Daniel O Claassen; K Richard Ridderinkhof; Peter Hedera; Madaline B Harrison; Scott A Wylie
Journal:  J Int Neuropsychol Soc       Date:  2015-12-28       Impact factor: 2.892

9.  Monitoring supports performance in a dual-task paradigm involving a risky decision-making task and a working memory task.

Authors:  Bettina Gathmann; Johannes Schiebener; Oliver T Wolf; Matthias Brand
Journal:  Front Psychol       Date:  2015-02-17

10.  Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability.

Authors:  Ashley D Radomski; Christopher Power; Scot E Purdon; Derek J Emery; Gregg Blevins; Kenneth G Warren; Esther Fujiwara
Journal:  BMC Neurol       Date:  2015-04-23       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.